Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Zaiss, Mario M
MetadataShow full item record
AbstractMicrobial metabolites are known to modulate immune responses of the host. The main metabolites derived from microbial fermentation of dietary fibers in the intestine, short-chain fatty acids (SCFA), affect local and systemic immune functions. Here we show that SCFA are regulators of osteoclast metabolism and bone mass in vivo. Treatment of mice with SCFA as well as feeding with a high-fiber diet significantly increases bone mass and prevents postmenopausal and inflammation-induced bone loss. The protective effects of SCFA on bone mass are associated with inhibition of osteoclast differentiation and bone resorption in vitro and in vivo, while bone formation is not affected. Mechanistically, propionate (C3) and butyrate (C4) induce metabolic reprogramming of osteoclasts resulting in enhanced glycolysis at the expense of oxidative phosphorylation, thereby downregulating essential osteoclast genes such as TRAF6 and NFATc1. In summary, these data identify SCFA as potent regulators of osteoclast metabolism and bone homeostasis.
CitationShort-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. 2018, 9 (1):55 Nat Commun
AffiliationHelmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/
- Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms.
- Authors: Lin HV, Frassetto A, Kowalik EJ Jr, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G, Marsh DJ
- Issue date: 2012
- Quantification of in Vivo Colonic Short Chain Fatty Acid Production from Inulin.
- Authors: Boets E, Deroover L, Houben E, Vermeulen K, Gomand SV, Delcour JA, Verbeke K
- Issue date: 2015 Oct 28
- RARγ is a negative regulator of osteoclastogenesis.
- Authors: Green AC, Poulton IJ, Vrahnas C, Häusler KD, Walkley CR, Wu JY, Martin TJ, Gillespie MT, Chandraratna RA, Quinn JM, Sims NA, Purton LE
- Issue date: 2015 Jun
- Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources.
- Authors: Beyer-Sehlmeyer G, Glei M, Hartmann E, Hughes R, Persin C, Böhm V, Rowland I, Schubert R, Jahreis G, Pool-Zobel BL
- Issue date: 2003 Dec
- Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
- Authors: Kneissel M, Luong-Nguyen NH, Baptist M, Cortesi R, Zumstein-Mecker S, Kossida S, O'Reilly T, Lane H, Susa M
- Issue date: 2004 Nov